Sara Monteiro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sara Monteiro has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Aljosa Celebic
Department of Medical Informatics, LIH, Strassen, Luxembourg
1 shared publication - Arjan Blokland
Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, the Netherlands
1 shared publication - Aurélie Fischer
Department of Precision Health, Luxembourg Institute of Health (LIH), Strassen, Luxembourg
1 shared publication - Claire Pauly
Transversal Translational Medicine, Luxembourg Institute of Health (LIH), Strassen, Luxembourg
1 shared publication - Coralie Dessenne
Science Office, Luxembourg Institute of Health, Strassen, Luxembourg
1 shared publication - Dmitry Bulaev
Competence Centre for Methodology and Statistics, Department of Medical Informatics, Luxembourg Institute of Health, Luxembourg
1 shared publication
Latest Publications
- Open Access
- 7 September 2026
- Published by Center for Open Science in PsyArXiv
Rethinking Gender Differences in Camouflaging: Multivariate Associations Across Compensation, Masking, and Assimilation
Background: Studies often report higher camouflaging among autistic women, whereas female-male differences are less consistent outside diagnosed autistic samples. Whether differences persist after accounting for empathizing, systemizing, and autistic traits remains unclear. We examined relationships across Camouflaging Autistic Traits Questionnaire (CAT-Q) strategies in adults without a reported autism diagnosis.Methods: We analyzed digitally collected data from 193 adults (75.1% women; mean age = 22.0 years, SD = 5.53). Multivariate models examined Compensation, Masking, and Assimilation. Sequential models tested Gender differences adjusted for Age, adjustment for Empathizing, Systemizing, and Autistic Traits, and Gender-by-trait interactions. We pooled estimates across 20 imputed datasets. Results: The age-adjusted model showed an omnibus Gender difference across CAT-Q subscales, Wald χ²(3) = 12.75, q = .006. Men reported higher Compensation (β = .596, q = .003) and CAT-Q total scores (β = .470, q = .007), whereas Masking and Assimilation did not differ by Gender. In the trait-adjusted model, the omnibus Gender effect was nonsignificant, Wald χ²(3) = 3.52, q = .368. Empathizing showed the strongest multivariate association with CAT-Q subscales, Wald χ²(3) = 71.89, q < .001; higher Empathizing was associated with lower Compensation (β = −.257, q = .003), Assimilation (β = −.450, q < .001), and total scores (β = −.321, q < .001). Systemizing and Autistic Traits showed no significant main effects after correction. The multivariate Gender × AQ-10 interaction was significant, Wald χ²(3) = 12.34, q = .025. The largest outcome-specific interaction involved Masking, although it did not survive coefficient-level correction (q = .065). Conclusion: Initial differences by Gender, driven by Compensation, attenuated after trait adjustment. Lower Empathizing was associated with greater Compensation and Assimilation, whereas Systemizing and Autistic Traits showed no robust main associations. Exploratory Gender × AQ-10 heterogeneity did not survive outcome-specific correction. Findings support strategy-specific rather than simple gender- or autistic-trait interpretations of CAT-Q scores.
- 7 September 2026
- Published by Center for Open Science in PsyArXiv
Open AccessRethinking Gender Differences in Camouflaging: Multivariate Associations Across Compensation, Masking, and Assimilation
Background: Studies often report higher camouflaging among autistic women, whereas female-male differences are less consistent outside diagnosed autistic samples. Whether differences persist after accounting for empathizing, systemizing, and autistic traits remains unclear. We examined relationships across Camouflaging Autistic Traits Questionnaire (CAT-Q) strategies in adults without a reported autism diagnosis.Methods: We analyzed digitally collected data from 193 adults (75.1% women; mean age = 22.0 years, SD = 5.53). Multivariate models examined Compensation, Masking, and Assimilation. Sequential models tested Gender differences adjusted for Age, adjustment for Empathizing, Systemizing, and Autistic Traits, and Gender-by-trait interactions. We pooled estimates across 20 imputed datasets. Results: The age-adjusted model showed an omnibus Gender difference across CAT-Q subscales, Wald χ²(3) = 12.75, q = .006. Men reported higher Compensation (β = .596, q = .003) and CAT-Q total scores (β = .470, q = .007), whereas Masking and Assimilation did not differ by Gender. In the trait-adjusted model, the omnibus Gender effect was nonsignificant, Wald χ²(3) = 3.52, q = .368. Empathizing showed the strongest multivariate association with CAT-Q subscales, Wald χ²(3) = 71.89, q < .001; higher Empathizing was associated with lower Compensation (β = −.257, q = .003), Assimilation (β = −.450, q < .001), and total scores (β = −.321, q < .001). Systemizing and Autistic Traits showed no significant main effects after correction. The multivariate Gender × AQ-10 interaction was significant, Wald χ²(3) = 12.34, q = .025. The largest outcome-specific interaction involved Masking, although it did not survive coefficient-level correction (q = .065). Conclusion: Initial differences by Gender, driven by Compensation, attenuated after trait adjustment. Lower Empathizing was associated with greater Compensation and Assimilation, whereas Systemizing and Autistic Traits showed no robust main associations. Exploratory Gender × AQ-10 heterogeneity did not survive outcome-specific correction. Findings support strategy-specific rather than simple gender- or autistic-trait interpretations of CAT-Q scores.
- Open Access
Cognitive Profiling and Validation of a Digital Cognitive Assessment Tool in Post-COVID-19 Condition: Protocol for a Single-Center, Cross-Sectional Study (DigiCog Study)
Background: Cognitive impairment is among the most frequently reported and disabling persistent symptoms following SARS-CoV-2 infection. Despite growing evidence of its prevalence, the characterization of domain-specific cognitive profiles and the identification of modifiable factors influencing cognitive outcomes in post-COVID-19 condition (PCC) remains scarce. Digital cognitive assessment tools have emerged as scalable and examiner-independent alternatives to traditional neuropsychological testing, but their validation in post-infectious contexts is still limited. Objective: The DigiCog study aims to characterize cognitive profiles associated with PCC, to evaluate a novel digital cognitive assessment technology (ViewMind, VMTech) against standardized neuropsychological measures, and to explore the potential role of cognitive reserve (CR) proxies in shaping cognitive outcomes following SARS-CoV-2 infection. Methods: DigiCog is a single-center cross-sectional study conducted within the Luxembourgish Predi-COVID cohort ( NCT04380987 ). Participants aged 25–65 years, with and without persistent COVID-19 symptoms, are invited to participate. Cognitive assessments are performed during face-to-face sessions by trained nurses and neuropsychologists using both the VMTech device and standardized neuropsychological tests. Additional data on PCC symptom status, CR, sociodemographic characteristics, fatigue, and psychological factors are also collected. Agreement between digital and standard cognitive assessments will be evaluated using Cohen’s kappa coefficient, with sensitivity, specificity, and receiver operating characteristic analyses as secondary measures. Cognitive performance will be compared between participants with and without PCC, and associations with CR proxies will be explored. Results: Participant recruitment began in May 2023. As of March 2025, 199 participants had been enrolled. Data collection has been completed. Data processing and statistical analyses are ongoing. Conclusions: The DigiCog study will provide new insights into cognitive functioning in PCC and evaluate the validity of a novel digital cognitive assessment approach. By integrating neuropsychological testing, digital assessment, and cognitive reserve, the study may inform scalable and more personalized approaches to cognitive screening and monitoring in post-infectious conditions. Study registration: ClinicalTrials.gov NCT06391970 ; Luxembourg National Research Ethics Committee approval No. 202208/05.
Open AccessCognitive Profiling and Validation of a Digital Cognitive Assessment Tool in Post-COVID-19 Condition: Protocol for a Single-Center, Cross-Sectional Study (DigiCog Study)
Background: Cognitive impairment is among the most frequently reported and disabling persistent symptoms following SARS-CoV-2 infection. Despite growing evidence of its prevalence, the characterization of domain-specific cognitive profiles and the identification of modifiable factors influencing cognitive outcomes in post-COVID-19 condition (PCC) remains scarce. Digital cognitive assessment tools have emerged as scalable and examiner-independent alternatives to traditional neuropsychological testing, but their validation in post-infectious contexts is still limited. Objective: The DigiCog study aims to characterize cognitive profiles associated with PCC, to evaluate a novel digital cognitive assessment technology (ViewMind, VMTech) against standardized neuropsychological measures, and to explore the potential role of cognitive reserve (CR) proxies in shaping cognitive outcomes following SARS-CoV-2 infection. Methods: DigiCog is a single-center cross-sectional study conducted within the Luxembourgish Predi-COVID cohort ( NCT04380987 ). Participants aged 25–65 years, with and without persistent COVID-19 symptoms, are invited to participate. Cognitive assessments are performed during face-to-face sessions by trained nurses and neuropsychologists using both the VMTech device and standardized neuropsychological tests. Additional data on PCC symptom status, CR, sociodemographic characteristics, fatigue, and psychological factors are also collected. Agreement between digital and standard cognitive assessments will be evaluated using Cohen’s kappa coefficient, with sensitivity, specificity, and receiver operating characteristic analyses as secondary measures. Cognitive performance will be compared between participants with and without PCC, and associations with CR proxies will be explored. Results: Participant recruitment began in May 2023. As of March 2025, 199 participants had been enrolled. Data collection has been completed. Data processing and statistical analyses are ongoing. Conclusions: The DigiCog study will provide new insights into cognitive functioning in PCC and evaluate the validity of a novel digital cognitive assessment approach. By integrating neuropsychological testing, digital assessment, and cognitive reserve, the study may inform scalable and more personalized approaches to cognitive screening and monitoring in post-infectious conditions. Study registration: ClinicalTrials.gov NCT06391970 ; Luxembourg National Research Ethics Committee approval No. 202208/05.
- Open Access
Long COVID cognitive sequelae 6 months postinfection and beyond: a scoping review protocol
Introduction The novel and expanding field of long COVID research has undergone diverse methodological approaches in recent years. This protocol lays out the methodological approach, which aims at identifying nuances in current research. It underscores the necessity for a more precise understanding of prolonged cognitive sequelae and their relation to initial disease severity. The findings will add valuable insights for the development of targeted rehabilitation, healthcare interventions and thereby aid patients, clinicians, policymakers and researchers. Our upcoming research is introduced here. Methods and analysis To map current research in the field, a scoping review will be conducted and documented in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Review Extension standards. A systematic search of scientific databases (PubMed, EMBASE), presented 1409 eligible results, published up to 21 December 2023. After removal of duplicates, 925 articles were extracted for screening. Two independent reviewers will screen for titles, abstracts and full texts, to extract data, which will then be organised using charting software. Data for various variables, that is, journal info, studied population demographics, study design, long COVID related data, cognitive outcomes and neuropsychological tests will be gathered. Descriptive analyses, evidence gap maps, heat map quantifications and narrative synthesis will be conducted for reporting of results. This scoping review has been registered with the Open Science Framework (https://doi.org/10.17605/OSF.IO/JHFX6). Ethics and dissemination Ethical approval is not required, as the study does not involve human participants. The findings will be disseminated through a publication in a scientific journal and within the professional network.
Open AccessLong COVID cognitive sequelae 6 months postinfection and beyond: a scoping review protocol
Introduction The novel and expanding field of long COVID research has undergone diverse methodological approaches in recent years. This protocol lays out the methodological approach, which aims at identifying nuances in current research. It underscores the necessity for a more precise understanding of prolonged cognitive sequelae and their relation to initial disease severity. The findings will add valuable insights for the development of targeted rehabilitation, healthcare interventions and thereby aid patients, clinicians, policymakers and researchers. Our upcoming research is introduced here. Methods and analysis To map current research in the field, a scoping review will be conducted and documented in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Review Extension standards. A systematic search of scientific databases (PubMed, EMBASE), presented 1409 eligible results, published up to 21 December 2023. After removal of duplicates, 925 articles were extracted for screening. Two independent reviewers will screen for titles, abstracts and full texts, to extract data, which will then be organised using charting software. Data for various variables, that is, journal info, studied population demographics, study design, long COVID related data, cognitive outcomes and neuropsychological tests will be gathered. Descriptive analyses, evidence gap maps, heat map quantifications and narrative synthesis will be conducted for reporting of results. This scoping review has been registered with the Open Science Framework (https://doi.org/10.17605/OSF.IO/JHFX6). Ethics and dissemination Ethical approval is not required, as the study does not involve human participants. The findings will be disseminated through a publication in a scientific journal and within the professional network.